Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019.
J Infect Dis
; 225(2): 208-213, 2022 01 18.
Article
en En
| MEDLINE
| ID: mdl-34618885
ABSTRACT
The burden of coronavirus disease 2019 (COVID-19) in children represents a fraction of cases worldwide, yet a subset of those infected are at risk for severe disease. We measured plasma severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in a cohort of 103 children hospitalized with COVID-19 with diverse clinical manifestations. SARS-CoV-2 RNAemia was detected in 27 (26%) of these children, lasted for a median of 6 (interquartile range, 2-9) days, and was associated with higher rates of oxygen administration, admission to the intensive care unit, and longer hospitalization.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Prueba de Ácido Nucleico para COVID-19
/
SARS-CoV-2
/
COVID-19
Idioma:
En
Revista:
J Infect Dis
Año:
2022
Tipo del documento:
Article